Raman and autofluorescence spectroscopy for in situ identification of neoplastic tissue during surgical treatment of brain tumors

Ortrud Uckermann(University Hospital Carl Gustav Carus), Roberta Galli(Ospedale Filippo Del Ponte Varese), Stephan B. Sobottka(University Hospital Carl Gustav Carus), Mido Max Hijazi(University Hospital Carl Gustav Carus), Matthias Meinhardt(Technische Universität Dresden), Gabriele Schackert(University Hospital Carl Gustav Carus), Tareq A. Juratli(University Hospital Carl Gustav Carus), Sven Richter(AbbVie (United States)), Ilker Y. Eyüpoglu(University Hospital Carl Gustav Carus), Jonathan Ziegler(Technische Universität Dresden), Dietmar Krex
Journal of Neuro-Oncology
August 28, 2024
10.1007/s11060-024-04809-w
Cited by 12

Related Papers

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
|The Lancet|2019|581
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
|JAMA Oncology|2022|411
On chemistry of γ-chitin
|Carbohydrate Polymers|2017|340